Westfield Capital Management Co. LP Buys 262,370 Shares of Masimo Co. (NASDAQ:MASI)

Westfield Capital Management Co. LP boosted its stake in shares of Masimo Co. (NASDAQ:MASI - Free Report) by 23.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,394,056 shares of the medical equipment provider's stock after buying an additional 262,370 shares during the period. Masimo comprises 0.8% of Westfield Capital Management Co. LP's investment portfolio, making the stock its 23rd largest holding. Westfield Capital Management Co. LP owned about 2.60% of Masimo worth $185,869,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the company. Thrivent Financial for Lutherans boosted its position in shares of Masimo by 42.1% in the second quarter. Thrivent Financial for Lutherans now owns 1,217,357 shares of the medical equipment provider's stock worth $153,314,000 after buying an additional 360,497 shares during the period. Point72 Asset Management L.P. grew its stake in Masimo by 107.8% during the 2nd quarter. Point72 Asset Management L.P. now owns 677,677 shares of the medical equipment provider's stock valued at $85,347,000 after acquiring an additional 351,523 shares in the last quarter. Farallon Capital Management LLC increased its holdings in shares of Masimo by 13.6% in the 1st quarter. Farallon Capital Management LLC now owns 1,489,563 shares of the medical equipment provider's stock valued at $218,742,000 after purchasing an additional 177,914 shares during the period. Dimensional Fund Advisors LP lifted its position in shares of Masimo by 45.9% in the second quarter. Dimensional Fund Advisors LP now owns 525,594 shares of the medical equipment provider's stock worth $66,201,000 after purchasing an additional 165,257 shares in the last quarter. Finally, ING Groep NV boosted its holdings in shares of Masimo by 143.3% during the third quarter. ING Groep NV now owns 240,900 shares of the medical equipment provider's stock worth $32,119,000 after purchasing an additional 141,900 shares during the period. 85.96% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the stock. Raymond James raised shares of Masimo from a "market perform" rating to an "outperform" rating and set a $170.00 target price for the company in a research note on Wednesday, November 6th. Piper Sandler lifted their price objective on Masimo from $165.00 to $180.00 and gave the company an "overweight" rating in a research report on Wednesday, November 6th. Wells Fargo & Company raised their price target on Masimo from $160.00 to $171.00 and gave the stock an "overweight" rating in a research note on Wednesday, November 6th. Stifel Nicolaus reissued a "buy" rating and issued a $190.00 price target (up previously from $170.00) on shares of Masimo in a research note on Friday. Finally, BTIG Research raised their price objective on shares of Masimo from $166.00 to $170.00 and gave the company a "buy" rating in a research report on Monday, October 14th. Three analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $167.00.

Masimo Trading Up 2.3 %

Shares of NASDAQ:MASI traded up $3.84 during trading on Friday, hitting $172.96. 1,036,209 shares of the company's stock were exchanged, compared to its average volume of 648,157. The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50. The firm has a market cap of $9.26 billion, a P/E ratio of 119.28 and a beta of 0.97. The firm has a 50-day moving average price of $143.48 and a two-hundred day moving average price of $127.94. Masimo Co. has a 1-year low of $91.60 and a 1-year high of $174.34.

Masimo (NASDAQ:MASI - Get Free Report) last released its quarterly earnings data on Tuesday, November 5th. The medical equipment provider reported $0.98 EPS for the quarter, beating analysts' consensus estimates of $0.84 by $0.14. Masimo had a return on equity of 14.98% and a net margin of 3.85%. The business had revenue of $504.60 million during the quarter, compared to the consensus estimate of $502.87 million. During the same quarter in the prior year, the company posted $0.63 earnings per share. The firm's revenue was up 5.4% on a year-over-year basis. Equities analysts predict that Masimo Co. will post 4.04 earnings per share for the current year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.